Alligator Bioscience AB on Muck Rack

Alligator Bioscience AB

As seen in: Color Research & Application
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alligator Bioscience

Contact Alligator Bioscience, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies

|
By Uppsala Sweden, Dorte Lisbet Nielsen, Alligator Bioscience AB, Peter Ellmark
| Arthritis & Rheumatology Verified
The full text of this article hosted at iucr.org is unavailable due to technical difficulties. Research Article First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies Sandra M. M.
Open in Who Shared Issue with article?

Alligator Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 10-03-2017]

|
By Alligator Bioscience AB
| bioportfolio.co.uk
Alligator Bioscience AB (Alligator Bioscience) is a biotechnology company that discovers and develops antibody based immunotherapies for the treatment of cancer. The company develops immuno-oncology compounds using its proprietary technology platforms, Alligator-Gold, a synthetic svFv library which contains several billion distinct fully human antibodies; and fragment induced diversity (FIND), an in vitro based antibody and protein optimization technology.
Open in Who Shared Issue with article?

Alligator Bioscience AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 22-02-2017]

|
By Alligator Bioscience AB
| bioportfolio.co.uk
Alligator Bioscience AB (Alligator Bioscience) is a biotechnology company that discovers and develops antibody based immunotherapies for the treatment of cancer. The company develops immuno-oncology compounds using its proprietary technology platforms, Alligator-Gold, a synthetic svFv library which contains several billion distinct fully human antibodies; and fragment induced diversity (FIND), an in vitro based antibody and protein optimization technology.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified